Positive correlation between PPARγ/PGC-1α and γ-GCS in lungs of rats and patients with chronic obstructive pulmonary disease

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 9, 2010, Pages 603-614

  Li, Jie ^a   Dai, Aiguo ^a   Hu, Ruicheng ^a   Zhu, Liming ^a   Tan, Shuangxiang ^a  

^a Hunan Province Geriatric Hospital   (China)

Author keywords

glutamylcysteine synthetase; chronic obstructive pulmonary disease; peroxisome proliferator activated receptor coactivator 1; peroxisome proliferator activated receptor gamma

Indexed keywords

RATTUS;

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUTAMATE CYSTEINE LIGASE; HEAT SHOCK PROTEIN; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PPARGC1A PROTEIN, HUMAN; PPARGC1A PROTEIN, RAT; REACTIVE OXYGEN METABOLITE; RNA BINDING PROTEIN; ROSIGLITAZONE; TRANSCRIPTION FACTOR;

AGED; ANIMAL; ARTICLE; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKE; SPRAGUE DAWLEY RAT; TOBACCO; WESTERN BLOTTING;

AGED; ANIMALS; BLOTTING, WESTERN; FEMALE; GLUTAMATE-CYSTEINE LIGASE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOPOLYSACCHARIDES; LUNG; MALE; MIDDLE AGED; PPAR GAMMA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SMOKE; THIAZOLIDINEDIONES; TOBACCO; TRANSCRIPTION FACTORS;

EID: 77956291601     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq071     Document Type: Article

References (21)

1. Murarescu ED, Mitrofan EC and Mihailovici MS. Chronic obstructive pulmonary disease in a new concept. Rom J Morphol Embryol 2007, 48: 207-214.
2. Rahman I, Li XY, Donaldson K, Harrison DJ and MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 1995, 269: L285-L292.
3. Seelig GF and Meister A. Gamma-glutamylcysteine synthetase interactions of an essential sulfhydryl group. J Biol Chem 1984, 259: 3534-3538.
4. Cortes-Wanstreet MM, Giedzinski E, Limoli CL and Luderer U. Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumor cells against oxidative and gamma-radiation-induced cell death. Mutagenesis 2009, 24: 211-224.
5. Issemann I and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347: 645-650.
6. Marx N, Duez H, Fruchart JC and Staels B. Peroxisome proliferatoractivated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 2004, 94: 1168-1178.
7. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P and Megret J, et al. Regulation of peroxisome proliferatoractivated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001, 164: 1487-1494.
8. Spears M, McSharry C and Thomson NC. Peroxisome proliferatoractivated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 2006, 36: 1494-1504.
9. Okuno Y, Matsuda M, Miyata Y, Fukuhara A, Komuro R, Shimabukuro M and Shimomura I. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. Endocr J 2010, 57: 303-309.
10. Li Y, Kovach A, Suino-Powell K, Martynowski D and Xu HE. Structural and biochemical basis for the binding selectivity of peroxisome proliferator- activated receptor gamma to PGC-1alpha. J Biol Chem 2008, 283: 19132-19139.
11. Valle I, Alvarez-Barrientos A, Arza E, Lamas S and Monsalve M. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 2005, 66: 562-573.
12. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S and Handschin C, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127: 397-408.
13. Esterbauer H, Oberkofler H, Krempler F and Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 1999, 62: 98-102.
14. Song YP, Cui DJ and Mao PY. A new way of establishing a rat chronic obstructive pulmonary disease model and the effects of drugs on them. Chin J Intern Med 2000, 39: 556-557.
15. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P and Fukuchi Y, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176: 532-555.
16. Seelig GF, Simondsen RP and Meister A. Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. J Biol Chem 1984, 259: 9345-9347.
17. Fu DY, Dai AG, Hu RC, Chen YR and Zhu LM. Expression and role of factor inhibiting hypoxia-inducible factor-1 in pulmonary arteries of rat with hypoxia-induced hypertension. Acta Biochim Biophys Sin 2008, 40: 883-892.
18. Lin SD, Dai AG and Xu P. Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2005, 28: 97-101.
19. Soler N, Ewig S, Torres A, Filella X, Gonzalez J and Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14: 1015-1022.
20. Ahn KO, Lim SW, Yang HJ, Li C, Sugawara A, Ito S and Choi BS, et al. Induction of PPAR gamma mRNA and protein expression by rosiglitazone in chronic cyclosporine nephropathy in the rat. Yonsei Med J 2007, 48: 308-316.
21. Lin SD and Dai AG. The activity and expression of g-glutamylcsteine sythetase in major organs of rats with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2007, 26: 161-164. 169.